Tesamorelin

Stabilised GHRH(1-44) analogue for growth-hormone axis research.

Dosages

Vial

39,55 €incl. VAT / 1 Vial

In stock

Payment by bank transfer

Verified purity
Every batch is analysed for identity and purity before it ships.
Discreet packaging
Plain outer packaging with no product details visible from the outside.
Tracked delivery
Dispatch within one working day with tracked shipping across Europe.

For research purposes only. Not intended for human consumption. For use by professionals only.

Description

Tesamorelin (TH9507) is a synthetic analogue of growth hormone-releasing hormone, stabilised as a 44-amino-acid GHRH(1-44) peptide with an N-terminal modification that increases resistance to enzymatic degradation compared with native GHRH. It is studied for GHRH-receptor binding on pituitary somatotrophs and downstream growth hormone/IGF-1 axis signalling. Supplied as a 5mg and 10 mg lyophilised vial; it is sensitive to agitation, so swirl rather than shake after adding diluent.

Storage and handling

Keep the sealed vial refrigerated between 2 and 8 °C and away from direct light. Do not freeze unless your protocol requires it.

Once reconstituted, keep the vial sealed and refrigerated, and aliquot rather than warming and cooling the same container repeatedly. Note the reconstitution date on the label.

Most products in the range ship as a lyophilised powder and need bacteriostatic water before use, which we stock separately.